A lower eGFRcystatin C/eGFRcreatinine ratio is associated with greater cardiovascular risk (higher Framingham Risk Score) in Chinese patients with newly diagnosed type 2 diabetes mellitus
Background Cardiovascular disease (CVD) is the leading cause of mortality in type 2 diabetes mellitus (T2DM) patients. Shrunken pore syndrome (SPS) is defined as eGFRcystatin C/eGFRcreatinine ratio <0.70 and predicts high CVD mortality. The Framingham Risk Score (FRS) is used to estimate an indiv...
Saved in:
| Main Authors: | Yan Yang, Bixia Yang, Shizhu Zhao, Shusu Liu, Hua Zhou, Ning Xu, Min Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2346267 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
eGFRCystatin C, difference between eGFRCystatin C and eGFRCre and heart failure: Insight from the NHANES 2001–2002 and Mendelian randomization analysis
by: Zhiyu Gu, et al.
Published: (2024-12-01) -
William Kannel y el estudio Framingham
by: Eduardo Álvarez Acevedo
Published: (2022-04-01) -
Evaluation of Race-Neutral Glomerular Filtration Rate Estimating Equations in an Indian Population
by: Ashok Kumar Yadav, et al.
Published: (2024-12-01) -
Research advances of shrunken pore syndrome
by: Zhang Pei, et al.
Published: (2022-03-01) -
Association of MPO levels with cardiometabolic disease stratified by atherosclerotic cardiovascular risk and intensity of therapy in a workforce population
by: Olga A. Iakoubova, et al.
Published: (2025-04-01)